logo

For the Inventor, By the Inventor

Skokie, IL, United States of America

Robert Elghanian

USPTO Granted Patents = 43 

 

Average Co-Inventor Count = 5.4

ph-index = 30

Forward Citations = 2,328(Granted Patents)


Location History:

  • Skokie, IL (US) (2003 - 2007)
  • Chicago, IL (US) (2002 - 2011)
  • Wilmette, IL (US) (2006 - 2014)
  • Evanston, IL (US) (2020)

Company Filing History:

goldMedal33 out of 62 
 
Nanosphere, Inc.
 patents
silverMedal5 out of 22 
 
Nanoink, Inc.
 patents
bronzeMedal3 out of 2,119 
 
Northwestern University
 patents
4. 2 out of 45 
 
Amersham Biosciences Ab
 patents

Years Active: 2002-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Specimen Preparation
Capillary Forces
Centrifugal Forces
Sample Collection
Nanoparticles
Oligonucleotides
Micrometric Direct-Write
Conductive Material
Nanolithography
Phase Shift Masks
Additive Repair
Biochip Analysis
43 patents (USPTO):Explore Patents
1. 10843195 - Devices, systems, and methods for specimen preparation using capillary and centrifugal forces (2020-11-24),
2. 8841127 - Methods and devices for sample collection, treatment and dispensing (2014-09-23),
3. 8323888 - Nanoparticles having oligonucleotides attached thereto and uses therefor (2012-12-04),
4. 8071168 - Micrometric direct-write methods for patterning conductive material and applications to flat panel display repair (2011-12-06),
5. 7829735 - Universal phosphoramidite for preparation of modified biomolecules and surfaces (2010-11-09),
6. 7762638 - Methods and apparatus for ink delivery to nanolithographic probe systems (2010-07-27),
7. 7691541 - Methods for additive repair of phase shift masks by selectively depositing nanometer-scale engineered structures on defective phase shifters (2010-04-06),
8. 7491422 - Direct-write nanolithography method of transporting ink with an elastomeric polymer coated nanoscopic tip to form a structure having internal hollows on a substrate (2009-02-17),
9. 7259252 - Nanoparticles having oligonucleotides attached thereto and uses therefor (2007-08-21),
10. 7098320 - Nanoparticles having oligonucleotides attached thereto and uses therefor (2006-08-29),
11. 7034854 - Methods and apparatus for ink delivery to nanolithographic probe systems (2006-04-25),
12. 6986992 - P450 single nucleotide polymorphism biochip analysis (2006-01-17),
13. 6986989 - Nanoparticles having oligonucleotides attached thereto and uses therefor (2006-01-17),
14. 6984491 - Nanoparticles having oligonucleotides attached thereto and uses therefor (2006-01-10),
15. 6969761 - Nanoparticles having oligonucleotides attached thereto and uses therefor (2005-11-29),

Title: The Innovative Journey of Robert Elghanian

Introduction: Robert Elghanian, a visionary inventor based in Skokie, IL (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Robert Elghanian's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device designed to improve patient outcomes in critical care settings.

Career Highlights: Throughout his illustrious career, Robert Elghanian has been recognized for his innovative spirit and dedication to pushing the boundaries of technological advancement. His work has led to numerous patents in various industries, solidifying his reputation as a pioneering inventor.

Collaborations: Robert Elghanian has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have been instrumental in turning his visionary ideas into tangible products that have had a positive impact on society.

Conclusion: In conclusion, Robert Elghanian's passion for innovation and relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to think outside the box and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…